0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Brief Communications |

Isoniazid Induction of Antinuclear Antibodies: A Prospective Study

NAOMI F. ROTHFIELD, M.D.; WILLIAM F. BIERER, M.D.; and JANE W. GARFIELD, M.D.
[+] Article and Author Information

Portions of this paper have appeared in abstract form (Rothfield N, Bierer W, Garfield J: The induction of antinuclear antibodies by isoniazid: a prospective study. Arthritis Rheum 14:182-183, 1971).

▸Requests for reprints should be addressed to Naomi F. Rothfield, M.D.; Division of Rheumatic Diseases, University of Connecticut Health Center; Farmington, CT 06032.


Farmington, Connecticut, and New York, New York


©1978 American College of PhysiciansAmerican College of Physicians


Ann Intern Med. 1978;88(5):650-652. doi:10.7326/0003-4819-88-5-650
Text Size: A A A

We prospectively studied 102 patients admitted to the Chest Service with tuberculosis. Four patients (4%) had antinuclear antibodies before therapy and 22 patients (21.6%) developed antinuclear antibodies after treatment. None developed lupus erythematosus cells or signs or symptoms of systemic lupus erythematosus. Age and race were not related to the induction of antinuclear antibodies. The percent of positive sera was similar during and after 3 months of treatment, with higher titers after 3 months of therapy. Although patients were treated with various antituberculosis drugs, isoniazid alone or in combination with other drugs induced antinuclear antibodies.

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Topic Collections
PubMed Articles
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)